Rheumatic Disease Clinics of North America

Papers
(The TQCC of Rheumatic Disease Clinics of North America is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Copyright107
Contents64
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases45
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis35
The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network33
Osteoarthritis Treatment Guidelines from Six Professional Societies30
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis21
Machine Learning-Enhanced Autoantibody Discovery and Diagnostics in Systemic Autoimmune Rheumatic Diseases19
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children17
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis16
Copyright16
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy15
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica14
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota13
Artificial Intelligence in Musculoskeletal Imaging13
Forthcoming Issues13
COPA Syndrome from Diagnosis to Treatment13
Lessons Learned from the COVID-19 Pandemic in Rheumatology12
The Short and Long of COVID-1912
Taxonomy of Quality of Care Indicators12
Venous Thromboembolism in the Inflammatory Rheumatic Diseases11
Contributors11
Imaging Challenges and Developments in Large-vessel Vasculitis10
Copyright10
Contributors10
Expanding the Treatment Team9
Pulmonary Hypertension Associated with Connective Tissue Disease9
Copyright9
De novo Connective Tissue Disorders as Immune-related Adverse Events9
Contents9
Primary Cardiac Involvement in Systemic Sclerosis8
Newer Immunosuppressants for Rheumatologic Disease8
Daniel J McCarty, MD: A Giant of Rheumatology8
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events8
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease8
Scleroderma: Best Approaches to Patient Care7
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease7
Preventative Care in Scleroderma7
COVID-19 and Rheumatology7
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 20197
Charles L Christian7
Cardiac MRI in Rheumatic Disease6
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD6
Copyright6
Imaging of Pulmonary Manifestations of Connective Tissue Disease6
Sustainable Health Care and Advocacy for Rheumatologists6
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis6
E Carwile LeRoy, MD6
Contributors6
Imaging of the Major Salivary Glands in Rheumatic Disease5
The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies5
A Guide to Contemporary Clinical Practice Guidelines5
Global Rheumatology5
Heart Failure in Rheumatic Disease5
Contents5
The Challenges of New Biologic Therapies in Pediatrics5
Guideline Development and Implementation in Rheumatic Disease5
Forthcoming Issues4
Copyright4
Treatment Guidelines in Pediatric Rheumatic Diseases4
Impacts of Storms, Precipitation, Drought, and Water Quality on Rheumatic Diseases4
Contents4
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis4
Myositis4
Contributors4
Beyond Coronary Artery Disease4
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”4
Genetic Defects in Early-Onset Inflammatory Bowel Disease3
The Role of Psychology in Pediatric Rheumatic Diseases3
Dual-Energy Computed Tomography Applications in Rheumatology3
Health Care Utilization3
Emerging and Expanding Infections due to Climate Change of Concern to Rheumatologists3
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases3
Treatment Guidelines in Gout3
SARS-CoV-2 Infection and COVID-19 in Children3
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk3
Achieving Precision Medicine in Psoriatic Arthritis3
Copyright3
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury3
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases3
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis3
Expanding IPEX: Inborn Errors of Regulatory T Cells3
0.14953899383545